Publications

Strong life sciences demand fuels $82m sale of life sciences property
Transactions - AUGUST 2, 2022

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Strong life sciences demand fuels $82m sale of life sciences property

by Released

A joint venture between Jadian Capital and Graymark Capital has sold Fremont Labs, a recently renovated class A life sciences property totaling 89,000 square feet in Fremont, a city in California's San Francisco Bay Area.

Diversified Healthcare Trust (DHC) paid $82 million for the asset. This acquisition marks DHC’s fourth life science acquisition in the San Francisco Bay area and expands the company’s total Bay Area holdings to six.

Fremont Labs is positioned on a 4.7-acre site at 47071 Bayside Pkwy within the Central I-880 corridor of San Francisco. Given San Francisco’s rank as the second-largest life sciences market in the United States, the property is surrounded by major life sciences users and is close to a highly educated labor pool and to the world-class research institutions at San Jose State University, Stanford University and Santa Clara University.

Recently renovated in 2022, Fremont Labs is fully leased as the headquarters location for Alamar

Forgot your username or password?